Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center Experience.
Seet AOL, Tan AC, Tan TJ, Ng MCH, Tai DWM, Lam JYC, Tan GS, Gogna A, Too CW, Tan BS, Takano A, Lim A, Lim TH, Lim ST, Dent RA, Ang MK, Yap YS, Tan IBH, Choo SP, Toh CK, Lim EH, Farid M, Skanderup AJ, Iyer NG, Lim WT, Tan EH, Lim TKH, Tan DSW. Seet AOL, et al. Among authors: tan gs, tan ibh, tan eh, tan ac, tan bs, tan tj, tan dsw. JCO Precis Oncol. 2021 May 18;5:PO.20.00261. doi: 10.1200/PO.20.00261. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34250396 Free PMC article.
Carcinoma of unknown primary site.
Jain A, Tan TJ, Tan DS. Jain A, et al. Among authors: tan ds, tan tj. N Engl J Med. 2014 Nov 20;371(21):2039. doi: 10.1056/NEJMc1411384. N Engl J Med. 2014. PMID: 25409387 No abstract available.
What is the role of immunotherapy in breast cancer?
Tan TJ, Chan JJ, Kamis S, Dent RA. Tan TJ, et al. Chin Clin Oncol. 2018 Apr;7(2):13. doi: 10.21037/cco.2018.04.01. Chin Clin Oncol. 2018. PMID: 29764158 Free article. Review.
Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC.
Tan AC, Seet AOL, Lai GGY, Lim TH, Lim AST, Tan GS, Takano A, Tai DWM, Tan TJY, Lam JYC, Ng MCH, Tan WL, Ang MK, Kanesvaran R, Ng QS, Jain A, Rajasekaran T, Lim WT, Tan EH, Lim TKH, Tan DSW. Tan AC, et al. J Thorac Oncol. 2020 Dec;15(12):1928-1934. doi: 10.1016/j.jtho.2020.08.011. Epub 2020 Aug 28. J Thorac Oncol. 2020. PMID: 32866654 Free article.
Tissue-specific cell-free DNA degradation quantifies circulating tumor DNA burden.
Zhu G, Guo YA, Ho D, Poon P, Poh ZW, Wong PM, Gan A, Chang MM, Kleftogiannis D, Lau YT, Tay B, Lim WJ, Chua C, Tan TJ, Koo SL, Chong DQ, Yap YS, Tan I, Ng S, Skanderup AJ. Zhu G, et al. Among authors: tan i, tan tj. Nat Commun. 2021 Apr 13;12(1):2229. doi: 10.1038/s41467-021-22463-y. Nat Commun. 2021. PMID: 33850132 Free PMC article.
Complementary Sequential Circulating Tumor Cell (CTC) and Cell-Free Tumor DNA (ctDNA) Profiling Reveals Metastatic Heterogeneity and Genomic Changes in Lung Cancer and Breast Cancer.
Kong SL, Liu X, Tan SJ, Tai JA, Phua LY, Poh HM, Yeo T, Chua YW, Haw YX, Ling WH, Ng RCH, Tan TJ, Loh KWJ, Tan DS, Ng QS, Ang MK, Toh CK, Lee YF, Lim CT, Lim TKH, Hillmer AM, Yap YS, Lim WT. Kong SL, et al. Among authors: tan ds, tan sj, tan tj. Front Oncol. 2021 Jul 16;11:698551. doi: 10.3389/fonc.2021.698551. eCollection 2021. Front Oncol. 2021. PMID: 34336686 Free PMC article.
A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignancies.
Ho J, Heong V, Peng Yong W, Soo R, Ean Chee C, Wong A, Sundar R, Liang Thian Y, Gopinathan A, Yan Pang M, Koe P, Nathan Jeraj S, Pyar Soe P, Yar Soe M, Tang T, Ng MCH, Tai DWM, Tan TJY, Xu H, Chang H, Landesman Y, Shah J, Shacham S, Chin Lee S, Tan DSW, Cher Goh B, Tan DSP. Ho J, et al. Ther Adv Med Oncol. 2022 Apr 11;14:17588359221087555. doi: 10.1177/17588359221087555. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35432603 Free PMC article.
140 results